CHEMOURS NETHERLANDS BV

Their core work

Chemours Netherlands BV is the European base of Chemours Company, a global specialty chemicals producer spun off from DuPont in 2015, headquartered in Dordrecht where they operate production and R&D facilities. Their core business is fluoroproducts — refrigerants, fluoropolymers, and fluorochemicals — and their H2020 participation is driven by deploying proprietary materials (notably their Opteon HFO refrigerant line, including HFO-1336mzz-z) in industrial research settings. In the DryFiciency project they acted as a technology provider supplying working fluids for high-temperature industrial heat pumps; in SinFonia they engaged as a research participant to explore whether engineered bacteria could produce fluorinated compounds via biological routes — a strategic interest for a company whose entire product portfolio depends on fluorine chemistry. They are an industrial end-user and material supplier in consortia, not a research-driven actor.

What they specialise in

How they've shifted over time

In their early H2020 period (2016–2018), Chemours focused squarely on the performance applications of their refrigerant portfolio — specifically deploying low-GWP HFO working fluids in industrial heat pumps for waste-heat recovery, a direct commercial use case tied to EU energy efficiency targets. By 2019 their focus shifted toward the upstream chemistry question: can fluorination be achieved biologically rather than through conventional synthetic chemistry? The SinFonia project, targeting Pseudomonas putida as a biofluorination platform, signals that Chemours is hedging on long-term fluorine supply and regulation by investing in bio-based routes to fluorinated compounds — a meaningful strategic pivot for a traditional chemicals company.

Chemours appears to be moving from pure application-side deployment of existing fluorochemicals toward research into bio-based fluorine chemistry — suggesting future collaborations may centre on green chemistry, biotechnology, and sustainable fluorine sourcing rather than thermal energy systems alone.

How they like to work

Chemours consistently joins consortia as a specialist contributor rather than a leader — they have never coordinated an H2020 project, and their two participations split between full partner and third-party roles. Their consortia are large (DryFiciency alone accounts for most of their 32 unique partners across 13 countries), indicating they are comfortable operating in complex multi-stakeholder projects where they provide a defined material or technology input rather than managing the research programme. For potential partners, this means Chemours brings industrial credibility and proprietary materials but will not drive project management or carry administrative burden.

Chemours has worked with 32 unique partners spread across 13 countries — a remarkably broad network for only 2 projects, almost entirely attributable to DryFiciency's large industrial consortium. Their European footprint is pan-continental rather than regionally concentrated.

What sets them apart

Chemours is one of very few large industrial chemicals companies in H2020 whose participation spans both the thermal-fluids energy space and cutting-edge synthetic biology — the same fluorine chemistry underpins both, giving them an unusual cross-domain perspective. They bring something most academic or SME partners cannot: proprietary industrial-grade fluorinated materials (Opteon refrigerant line) available for real-world testing, plus the commercial pull needed to take research outcomes toward market. For a consortium that needs an industrial anchor with fluorine expertise, Chemours is essentially without direct peers in the Netherlands.

Highlights from their portfolio

• DryFiciency
  The largest and most commercially grounded of their two projects — a six-year IA consortium targeting waste-heat recovery in industrial drying, where Chemours supplied HFO-1336mzz-z as the working fluid for high-temperature heat pumps, placing their Opteon refrigerant technology into a real industrial validation context.
• SinFonia
  A strategically forward-looking RIA project in which Chemours participated (not merely as a third party) to explore whether Pseudomonas putida could be engineered for biofluorination — an unusual bet by a traditional chemicals company on biotechnology as a future route to its core product family.